Covid-19

Série de casos | Níveis mais altos de troponina foram associados com lesões cardíacas persistentes em RM em crianças com miocardite após vacinação contra COVID-19 baseada em mRNA

31 Jan, 2023 | 12:27h

Higher Troponin Levels on Admission are associated With Persistent Cardiac Magnetic Resonance Lesions in Children Developing Myocarditis After mRNA-Based COVID-19 Vaccination – The Pediatric Infectious Disease Journal

 

---

OMS atualiza diretrizes de COVID-19 sobre máscaras, tratamentos e cuidados do paciente

16 Jan, 2023 | 11:17h

WHO updates COVID-19 guidelines on masks, treatments and patient care – World Health Organization

Diretrizes OMS atualizadas:

Infection prevention and control in the context of coronavirus disease (COVID-19): a living guideline, 13 January 2023 – World Health Organization

Clinical management of COVID-19: Living guideline, 13 January 2023 – World Health Organization – World Health Organization

Therapeutics and COVID-19: Living guideline, 13 January 2023 – World Health Organization

 

---

Estudo randomizado | Fluvoxamina não é melhor que placebo em pacientes ambulatoriais com COVID-19 leve a moderada

16 Jan, 2023 | 11:12h

Effect of Fluvoxamine vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial – JAMA

Editorial: Lack of Benefit of Fluvoxamine for COVID-19 – JAMA

Entrevista com a autora: Fluvoxamine vs Placebo and Time to Sustained Recovery From Mild or Moderate COVID-19 – JAMA

Comentário: Trial finds that fluvoxamine doesn’t speed COVID recovery – CIDRAP

 

Comentário no Twitter

Among outpatients with mild to moderate #COVID19, treatment with 50 mg of fluvoxamine twice daily for 10 days, compared with placebo, did not improve time to sustained recovery. https://t.co/4QgBssqFSU pic.twitter.com/RMZ6mqlx6u

— JAMA (@JAMA_current) January 12, 2023

 

---

Revisão | COVID longa: principais achados, mecanismos e recomendações

16 Jan, 2023 | 11:08h

Long COVID: major findings, mechanisms and recommendations – Nature Reviews Microbiology

Conteúdo relacionado: Retrospective Study | Most patients with long Covid developed after mild infection get better within a year

 

---

Uma pesquisa sobre a aceitação da vacina contra COVID-19 em 23 países em 2022

16 Jan, 2023 | 11:07h

A survey of COVID-19 vaccine acceptance across 23 countries in 2022 – Nature Medicine

Comunicado de imprensa: Global COVID-19 vaccine acceptance rising but hesitancy remains – London School of Hygiene & Tropical Medicine

 

Comentário no Twitter

The third annual iteration of a survey assessing vaccine confidence in 23 countries shows the overall willingness to accept a COVID-19 vaccine has increased, although results were heteregeous across countries, according to a @NatureMedicine paper. https://t.co/0EkMH7oRdn pic.twitter.com/bLc98F9AYt

— Nature Portfolio (@NaturePortfolio) January 13, 2023

 

---

Estudo randomizado | Uso de zinco por via oral 2 vezes/dia no tratamento de pacientes com COVID-19.

13 Dez, 2022 | 15:16h

Twice-Daily Oral Zinc in the Treatment of Patients With Coronavirus Disease 2019: A Randomized Double-Blind Controlled Trial – Clinical Infectious Diseases

 

---

Incidência de miocardite/pericardite após vacinação contra COVID-19 com vacina mRNA entre crianças e jovens adultos nos EUA.

17 Out, 2022 | 13:38h

Incidence of Myocarditis/Pericarditis Following mRNA COVID-19 Vaccination Among Children and Younger Adults in the United States – Annals of Internal Medicine

Comunicado de imprensa: Incidence of myocarditis/pericarditis following mRNA COVID-19 vaccination among children, younger adults in the US – American College of Physicians

 

Comentário no Twitter (fio – clique para saber mais)

Let me me perfectly clear about the evidence for myocarditis after mRNA vaccines
1. There is a notable increased incidence, age 12-39, males, with each dose (Table)https://t.co/XXQbyeLiSP pic.twitter.com/wLTZT3fppy

— Eric Topol (@EricTopol) October 12, 2022

 

Comentário no Twitter

Let me me perfectly clear about the evidence for myocarditis after mRNA vaccines
1. There is a notable increased incidence, age 12-39, males, with each dose (Table)https://t.co/XXQbyeLiSP pic.twitter.com/wLTZT3fppy

— Eric Topol (@EricTopol) October 12, 2022

 

---

Estimativas das proporções globais de fadiga persistente e sintomas cognitivos e respiratórios após COVID-19 sintomática.

17 Out, 2022 | 12:55h

Estimated Global Proportions of Individuals With Persistent Fatigue, Cognitive, and Respiratory Symptom Clusters Following Symptomatic COVID-19 in 2020 and 2021 – JAMA

Comentários:

Women And Hospitalized Patients More Prone To Long Covid, Study Finds – Forbes

Nearly two-thirds of long COVID patients are female, global study finds – UPI

 

Comentário no Twitter

A new @IHME_UW modeling study on #LongCovid based upon 1.2 million people with Covid from 22 countrieshttps://t.co/evMcFVJ2vU @JAMA_current pic.twitter.com/qt1bgHkaVV

— Eric Topol (@EricTopol) October 10, 2022

 

---

Dois grandes estudos clínicos mostraram que suplementos de vitamina D não reduzem o risco de Covid-19.

13 Set, 2022 | 12:08h

Estudo 1: Effect of a test-and-treat approach to vitamin D supplementation on risk of all cause acute respiratory tract infection and covid-19: phase 3 randomised controlled trial (CORONAVIT) – The BMJ

Estudo 2: Prevention of covid-19 and other acute respiratory infections with cod liver oil supplementation, a low dose vitamin D supplement: quadruple blinded, randomised placebo controlled trial – The BMJ

Editorial: Can vitamin D protect against covid-19? – The BMJ

Comunicado de imprensa: No link between vitamin D supplements and reduced risk of covid-19 – BMJ Newsroom

 

---

Estudo de coorte | Patologia cardíaca de longo prazo em indivíduos que tiveram COVID-19 inicialmente leve.

12 Set, 2022 | 11:36h

Long-term cardiac pathology in individuals with mild initial COVID-19 illness – Nature Medicine

 

---